Stalicla

Recent Finacing

Equity

Recent Raise

$2.5M

Stalicla is a precision-medicine company developing treatments for neurodevelopmental and neuropsychiatric disorders, including autism and substance-use indications.

Founded 2017

Geneve, Switzerland

11-50

Private

stalicla.com